WBC subsets on day +42, before blinatumomab administration
| ID . | WBC per μL . | ANC per μL . | ALC per μL . | CD3+ cells per μL . | CD4+ cells per μL . | CD8+ cells per μL . | CD8:CD4 . |
|---|---|---|---|---|---|---|---|
| 1 | 5.5 | 4.2 | 0.7 | 357.8 | 212.3 | 130.3 | 0.61 |
| 2 | 5.1 | 3.7 | 0.8 | 533.3 | 269.9 | 229.5 | 0.85 |
| 3 | 4.3 | 2.7 | 1.1 | 928.5 | 189.2 | 249.4 | 1.32 |
| 4 | 4.4 | 3.2 | 0.6 | 849.6 | 442.7 | 371.1 | 0.84 |
| 5 | 9.6 | 5.5 | 3.2 | 3391.3 | 1921.1 | 1391.7 | 0.72 |
| 6 | 6.9 | 1.9 | 1.8 | 1622.7 | 1227.5 | 378.3 | 0.31 |
| 7 | 4.3 | 3 | 0.6 | 443.2 | 256.0 | 170.1 | 0.66 |
| 8 | 6 | 3.9 | 0.2 | 482.6 | 347.7 | 120.4 | 0.35 |
| 9 | 4.7 | 2.7 | 0.9 | 1458.7 | 1032.1 | 411.1 | 0.40 |
| 10 | 5.6 | 3.4 | 1.5 | 1415.5 | 883.6 | 423.7 | 0.48 |
| 11 | 4.9 | 2.7 | 1.4 | 1481.6 | 763.5 | 658.1 | 0.86 |
| 12 | 3.5 | 2.7 | 0.3 | 182.3 | 94.6 | 74.3 | 0.79 |
| 13 | 2.2 | 1.4 | 0.5 | 431.9 | 195.0 | 218.9 | 1.12 |
| 14 | 3.5 | 2.3 | 0.3 | 283.5 | 121.3 | 157.8 | 1.30 |
| ID . | WBC per μL . | ANC per μL . | ALC per μL . | CD3+ cells per μL . | CD4+ cells per μL . | CD8+ cells per μL . | CD8:CD4 . |
|---|---|---|---|---|---|---|---|
| 1 | 5.5 | 4.2 | 0.7 | 357.8 | 212.3 | 130.3 | 0.61 |
| 2 | 5.1 | 3.7 | 0.8 | 533.3 | 269.9 | 229.5 | 0.85 |
| 3 | 4.3 | 2.7 | 1.1 | 928.5 | 189.2 | 249.4 | 1.32 |
| 4 | 4.4 | 3.2 | 0.6 | 849.6 | 442.7 | 371.1 | 0.84 |
| 5 | 9.6 | 5.5 | 3.2 | 3391.3 | 1921.1 | 1391.7 | 0.72 |
| 6 | 6.9 | 1.9 | 1.8 | 1622.7 | 1227.5 | 378.3 | 0.31 |
| 7 | 4.3 | 3 | 0.6 | 443.2 | 256.0 | 170.1 | 0.66 |
| 8 | 6 | 3.9 | 0.2 | 482.6 | 347.7 | 120.4 | 0.35 |
| 9 | 4.7 | 2.7 | 0.9 | 1458.7 | 1032.1 | 411.1 | 0.40 |
| 10 | 5.6 | 3.4 | 1.5 | 1415.5 | 883.6 | 423.7 | 0.48 |
| 11 | 4.9 | 2.7 | 1.4 | 1481.6 | 763.5 | 658.1 | 0.86 |
| 12 | 3.5 | 2.7 | 0.3 | 182.3 | 94.6 | 74.3 | 0.79 |
| 13 | 2.2 | 1.4 | 0.5 | 431.9 | 195.0 | 218.9 | 1.12 |
| 14 | 3.5 | 2.3 | 0.3 | 283.5 | 121.3 | 157.8 | 1.30 |
ALC, absolute lymphocyte count; ANC, absolute neutrophile count.